Opportunity
DIBBS #SPE2DP-26-T-5203
DLA Solicitation for Moxifloxacin Hydrochloride Tablets, 400 mg, 30-count bottles
Posted
September 24, 2026
Respond By
September 29, 2026
Identifier
SPE2DP-26-T-5203
NAICS
424210
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA is soliciting Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle, for delivery to multiple military locations. - Government Buyer: - Defense Logistics Agency (DLA) - Sub-agency: DLA Troop Support Medical Supply Chain Pharmacy FSA - Buyer: Nicholas Quigley - OEMs and Vendors: - TEVA PHARMACEUTICALS USA, INC. (NDC00093-7387-56) - RISING PHARMA HOLDINGS, INC. (NDC57237-0156-30) - Products Requested: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle - NSN: 6505-01-503-4772 - Quantities: 3, 5, 7, 12, and 14 bottles across five line items - Part numbers: NDC00093-7387-56 (TEVA), NDC57237-0156-30 (Rising Pharma) - Notable Requirements: - Only approved OEMs and part numbers accepted - Packaging and marking must comply with MIL-STD-129 and Medical Marking Standard No. 1 - Delivery required within 20 days of award, FOB destination - Storage at controlled room temperature; avoid high humidity - Delivery Locations: - Multiple military sites including USS Lewis B Puller ESB 3, USS Sampson DDG 102, USS Paul Hamilton DDG 60, and engineer battalions
Description
MOXIFLOXACIN HYDROC (QTY: 5, NSN: 6505-01-503-4772, Purchase Request: 7016740478) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 12, NSN: 6505-01-503-4772, Purchase Request: 7016699423) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 7, NSN: 6505-01-503-4772, Purchase Request: 7016724053) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 14, NSN: 6505-01-503-4772, Purchase Request: 7016677258) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 3, NSN: 6505-01-503-4772, Purchase Request: 7016539944) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.